Trial Site Detail
Drug: |
CB-839 |
|||
|---|---|---|---|---|
Trial: |
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Active, not recruiting |
|||
Memorial Sloan Kettering1275 York Ave |
Principal Investigator: |
James Hardng, MD |
|---|---|
Contact: |
646-888-4226 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Memorial Sloan Kettering Website: |
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.